PhaseRx Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 21

Employees

  • Stock Symbol
  • PZRXQ

Stock Symbol

PhaseRx General Information

Description

PhaseRx Inc is a biopharmaceutical company. It is developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy, or i-ERT. The approach is enabled by proprietary Hybrid messenger RNA, or mRNA, Technology platform, which allows synthesis of the missing enzyme inside the cell. The product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency, or OTCD, argininosuccinate lyase deficiency, or ASL deficiency, and argininosuccinate synthetase deficiency, or ASS1 deficiency.

Contact Information

Website
www.phaserx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 410 West Harrison Street
  • Suite 300
  • Seattle, WA 98119
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 410 West Harrison Street
  • Suite 300
  • Seattle, WA 98119
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PhaseRx Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
5.44K

PhaseRx Financials Summary

As of 30-Sep-2017, PhaseRx has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2017 FY 2016 31-Dec-2016 FY 2015 31-Dec-2015 FY 2014 31-Dec-2014
EV 7,111 5,096
Revenue 0 0 375 1,200
EBITDA (12,955) (18,004) (5,397) (4,970)
Net Income (13,891) (20,137) (7,377) (6,849)
Total Assets 6,038 16,448 3,914 2,659
Total Debt 5,441 5,703 19,841 12,540
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PhaseRx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PhaseRx‘s full profile, request access.

Request a free trial

PhaseRx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore PhaseRx‘s full profile, request access.

Request a free trial

PhaseRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
PhaseRx Inc is a biopharmaceutical company. It is developing a portfolio of products for the treatment of inherited enzy
Biotechnology
Seattle, WA
21 As of 2016

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PhaseRx Competitors (1)

One of PhaseRx’s competitors is Oxb, a Corporation company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oxb Corporation Oxford, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

PhaseRx Patents

PhaseRx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018126084-A1 Branched peg molecules and related compositions and methods Inactive 30-Dec-2016
CA-2974503-A1 Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells Inactive 21-Jan-2015
JP-2021050212-A Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells Active 21-Jan-2015
WO-2016118697-A1 Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells Inactive 21-Jan-2015
WO-2016118697-A9 Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells Inactive 21-Jan-2015 A61K31/7105
To view PhaseRx’s complete patent history, request access »

PhaseRx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PhaseRx Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PhaseRx‘s full profile, request access.

Request a free trial

PhaseRx FAQs

  • When was PhaseRx founded?

    PhaseRx was founded in 2006.

  • Where is PhaseRx headquartered?

    PhaseRx is headquartered in Seattle, WA.

  • What is the size of PhaseRx?

    PhaseRx has 21 total employees.

  • What industry is PhaseRx in?

    PhaseRx’s primary industry is Biotechnology.

  • Is PhaseRx a private or public company?

    PhaseRx is a Public company.

  • What is PhaseRx’s stock symbol?

    The ticker symbol for PhaseRx is PZRXQ.

  • Who are PhaseRx’s competitors?

    Oxb is a competitor of PhaseRx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process